Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Nabriva Therapeutics (NBRVF) Stock Price & Analysis

1,010 Followers

NBRVF Stock Chart & Stats

$0.01$0.00(0.00%)
At close: 4:00 PM EST
$0$200$400Feb 28Mar 1Feb 28Mar 1Nov 15
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.01
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
0
Market Cap
$323
Enterprise Value
$4.21M
Total Cash (Recent Filing)
$2.18M
Total Debt (Recent Filing)
$540.00K
Price to Earnings (P/E)
0.0
Beta
58.77
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

NBRVF FAQ

What was Nabriva Therapeutics’s price range in the past 12 months?
Nabriva Therapeutics lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Nabriva Therapeutics’s market cap?
Nabriva Therapeutics’s market cap is $323.
When is Nabriva Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nabriva Therapeutics’s earnings last quarter?
Nabriva Therapeutics released its earnings results on May 11, 2023. The company reported -$2.718 earnings per share for the quarter.
Is Nabriva Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nabriva Therapeutics pay dividends?
Nabriva Therapeutics does not currently pay dividends.
What is Nabriva Therapeutics’s EPS estimate?
Nabriva Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nabriva Therapeutics have?
Nabriva Therapeutics has 3,230,837 shares outstanding.
What happened to Nabriva Therapeutics’s price movement after its last earnings report?
Nabriva Therapeutics reported an EPS of -$2.718 in its last earnings report. Following the earnings report the stock price went up 108.333%.
Which hedge fund is a major shareholder of Nabriva Therapeutics?
Currently, no hedge funds are holding shares in NBRVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology